The Framingham Heart Study is a project of Boston University & the National Heart, Lung, & Blood Institute.
The Framingham Heart Study is a project of Boston University & the National Heart, Lung, & Blood Institute.
Research Application Login For Researchers Research Application FAQ Data & Materials Distribution Agreement Review Committees Manuals of Procedures GWAS Pleiotropic Tool AHA Genome Phenome Study

For Researchers

The Framingham Heart Study welcomes the interest and proposals of outside investigators. Collaboration is encouraged as it helps to maximize the scientific value of the wealth of epidemiologic data made possible by the participation of more than 15,000 individuals who enrolled in the Framingham Heart Study over the past decades. The core research of the Heart Study has focused on many aspects of cardiovascular and cerebrovascular disease. Access to the data for a wide range of investigations has enabled research discoveries related to other diseases such as stroke, osteoporosis, arthritis, obesity, eye and hearing disorders, and cancer.

In order to facilitate access and ensure the optimal scientific outcome, the Framingham Heart Study provides ancillary study policy and procedures and a proposal application.

All FHS Research Applications require “Approval” or “Approval in concept” before investigators may submit to sponsors for funding.

Recent Updates

  1. **NEW 2019** A Guide for Investigators interested in FHS data
  2. NIH Deadlines for FHS Generation 3 Omni 2 Exam 4 Research:
    NOTICE OF NIH FHS RECEIPT DATES FOR GEN3 AND OMNI2 EXAM 4
    A0 Receipt Date Council
    (Council Cycle)
    Earliest Grant
    Start Date
    A1 Receipt Date Council
    (Council Cycle)
    Earliest Grant
    Start Date
    FHS Exam Start Date
    Jan 25 – May 7, 2020
    (R01: Feb 5, 2020)
    October 2020
    (Cycle I)
    December 2020 Sept 25, 2020 – Jan 7, 2021
    (R01: Nov 5, 2020)
    May 2021
    (Cycle III)
    July 2021 January 1, 2022
    (Exam 4 preparation
    begins 9/1/2021)
    May 25 – Sept 7, 2020
    (R01: June 5, 2020)
    January 2021
    (Cycle II)
    April 2021 Jan 25 – May 7, 2021
    (R01: March 5, 2021)
    October 2021
    (Cycle I)
    December 2021
    Sept 25, 2020 – Jan 7, 2021
    (R01: Oct 5, 2020)
    May 2021
    (Cycle III)
    July 2021 May 25 – Sept 7, 2021
    (R01: June 5, 2021)
    Jan 2022
    (Cycle II)
    April 2022
  3. Lab & DNA Committee Submission deadlines
    Submission deadlines and meeting frequency for DNA and Laboratory Committee applications have changed. Both committees now have application deadlines as follows:
    July 15, August 15, November 15, December 15, March 15, April 15
    Review meetings will convene 2 weeks after the submission deadline.